IDEX (NYSE:IEX) Announces Quarterly Earnings Results

Key Points

• IDEX beat quarterly expectations: Adjusted EPS rose 15% year over year to a record $2.33, exceeding estimates by $0.09, while revenue increased 8.3% to $951.7 million.
• Orders and profitability strengthened: Organic sales grew 8%, organic orders rose 13%, and adjusted EBITDA margin expanded 50 basis points to 27.8%, with momentum in data centers, semiconductors, space and defense, and municipal water.
• The company raised its 2026 outlook to 6.5%–6.8% organic growth and adjusted EPS of $8.91–$8.96; however, management noted weakness in chemicals, agriculture, parts of energy, and life sciences.

IDEX (NYSE:IEX - Get Free Report) issued its quarterly earnings data on Wednesday. The industrial products company reported $2.33 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.09, FiscalAI reports. IDEX had a return on equity of 15.69% and a net margin of 14.49%. The business had revenue of $951.70 million for the quarter, compared to analysts' expectations of $934.36 million. During the same period last year, the business earned $2.03 EPS. The business's revenue was up 8.3% on a year-over-year basis.

Here are the key takeaways from IDEX's conference call:

• Q3 exceeded expectations, with organic sales up 8%, adjusted EBITDA margin expanding 50 basis points to 27.8%, and adjusted EPS rising 15% to a record $2.33.
• Orders increased 13% organically to nearly $1 billion, with growth across all three segments and particularly strong momentum in HST, data centers, semiconductors, space and defense, and municipal water.
• IDEX raised its 2026 outlook, now expecting 6.5%–6.8% organic growth, 27.1%–27.3% adjusted EBITDA margins, and adjusted EPS of $8.91–$8.96; free-cash-flow conversion is still expected to exceed 100%.
• Free cash flow rose 14% to $214 million, leverage improved to 1.8x, and the company plans to continue roughly $75 million of quarterly share repurchases while maintaining an active bolt-on acquisition pipeline.
• Management cited continued weakness in chemicals, agriculture, and parts of energy, while life sciences remained flat due to a legacy-platform wind-down; data-center orders are strong but can be lumpy, and elevated acquisition valuations are encouraging continued M&A discipline.

IDEX Stock Performance

Shares of IEX stock traded up $3.15 during trading hours on Wednesday, hitting $236.37. 610,061 shares of the company were exchanged, compared to its average volume of 731,373. The firm has a fifty day simple moving average of $229.91 and a 200 day simple moving average of $215.17. The company has a current ratio of 3.05, a quick ratio of 2.15 and a debt-to-equity ratio of 0.46. IDEX has a 52-week low of $160.60 and a 52-week high of $243.80. The stock has a market capitalization of $17.42 billion, a price-to-earnings ratio of 33.96, a P/E/G ratio of 2.60 and a beta of 0.97.

IDEX Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 16th. Stockholders of record on Friday, October 2nd were given a dividend of $0.73 per share. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend was Friday, October 2nd. IDEX's dividend payout ratio is currently 42.01%.

Wall Street Analyst Weigh In

IEX has been the subject of a number of recent analyst reports. Oppenheimer upped their price objective on shares of IDEX from $270.00 to $275.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 21st. Royal Bank Of Canada lifted their target price on shares of IDEX from $280.00 to $285.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 14th. KeyCorp raised shares of IDEX to a "hold" rating in a research report on Monday, October 12th. Weiss Ratings upgraded IDEX from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, July 30th. Finally, Argus upped their target price on IDEX from $250.00 to $260.00 and gave the company a "buy" rating in a report on Thursday, August 6th. Nine investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $261.09.

Insider Activity at IDEX

In other IDEX news, CAO Lisa Anderson sold 385 shares of the firm's stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total value of $91,857.15. Following the completion of the sale, the chief accounting officer directly owned 4,327 shares of the company's stock, valued at $1,032,378.93. This trade represents a 8.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.50% of the company's stock.

About IDEX

IDEX Corporation is an industrial manufacturing company headquartered in Lake Forest, Illinois. The company designs and produces engineered products and technologies used to move, control, measure and apply fluids, as well as equipment used in fire and safety applications.

IDEX operates through businesses serving fluid and metering technologies, health and science technologies, and fire and safety markets. Its products include pumps, valves, flow meters, compressors, dispensing equipment, precision fluidics components and systems, fire pumps, rescue tools and other specialized equipment.

The company serves a broad range of industries, including healthcare, life sciences, water and wastewater, chemical processing, energy, food and beverage, agriculture, industrial manufacturing and municipal fire protection.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.